Evaluation of the Effects of LY2605541 on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus (BIDO)
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2016
Price : $35 *
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms BIDO
- 24 Mar 2016 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 27 Oct 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 14 Aug 2014 New trial record